Back

Benefit of modern P2Y12-inhibitors on long-term prognosis in patients with ST-elevation myocardial infarction with and without advanced chronic kidney disease

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Translational research in acute coronary syndrome registries ST-Elevation Myocardial Infarction (STEMI) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Johannes Schmucker

Hospital Links der Weser, Bremen (Germany)

6 More presentations in this session

Presentation thumbnail
Modulation of ischemic and bleeding risk by peripheral artery disease after an acute coronary syndrome
Doctor M. Cespon Fernandez (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
Impact of severe anemia (hemoglobin <10 g/dl) in the ischemic-bleeding profile during treatment with dual antiplatelet therapy after hospital discharge for acute coronary syndrome
Mrs I. Munoz Pousa (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
Temporal trends in latecomer ST-segment elevation myocardial infarction patients: Insights from the AMIS Plus Registry 1997-2017
Doctor M. Roberto (Biel, CH)
Abstract Slides Video
Presentation thumbnail
Optimal timing of invasive coronary angiography following NSTEMI
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI; 3-year cost-analysis data from COMPARE-ACUTE trial
Doctor P. Smits (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Translational research in acute coronary syndrome registries

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources